Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Takara Bio Inc. ( (JP:4974) ) is now available.
Takara Bio Inc. has completed the absorption-type merger of its wholly owned subsidiary, ViSpot, Inc., as part of its strategy to streamline management and accelerate business growth. The merger, effective May 1, 2025, is expected to have a minor impact on the company’s consolidated business performance.
More about Takara Bio Inc.
Takara Bio Inc. operates in the biotechnology industry, focusing on the manufacturing and sales of reagents and instruments, contract development and manufacturing organization (CDMO) services, and gene therapy business. The company is headquartered in Kusatsu, Shiga, Japan.
YTD Price Performance: -19.27%
Average Trading Volume: 337,351
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen100.1B
For detailed information about 4974 stock, go to TipRanks’ Stock Analysis page.